Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease

被引:103
|
作者
Church, Frank C. [1 ]
机构
[1] Univ N Carolina, Dept Pathol & Lab Med, Sch Med, Chapel Hill, NC 27599 USA
关键词
Parkinson's disease; neurodegenerative disorder; substantia nigra; carbidopa; levodopa; anti-inflammatory; antioxidants; integrative medicine; older adults; motor and non-motor symptoms; QUALITY-OF-LIFE; INTENSITY TREADMILL EXERCISE; IMPULSE CONTROL DISORDERS; VITAMIN-D; MITOCHONDRIAL-FUNCTION; CEREBROSPINAL-FLUID; ENDURANCE EXERCISE; ANIMAL-MODELS; THERAPY; NEUROPLASTICITY;
D O I
10.3390/biom11040612
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) usually presents in older adults and typically has both motor and non-motor dysfunctions. PD is a progressive neurodegenerative disorder resulting from dopaminergic neuronal cell loss in the mid-brain substantia nigra pars compacta region. Outlined here is an integrative medicine and health strategy that highlights five treatment options for people with Parkinson's (PwP): rehabilitate, therapy, restorative, maintenance, and surgery. Rehabilitating begins following the diagnosis and throughout any additional treatment processes, especially vis-a-vis consulting with physical, occupational, and/or speech pathology therapist(s). Therapy uses daily administration of either the dopamine precursor levodopa (with carbidopa) or a dopamine agonist, compounds that preserve residual dopamine, and other specific motor/non-motor-related compounds. Restorative uses strenuous aerobic exercise programs that can be neuroprotective. Maintenance uses complementary and alternative medicine substances that potentially support and protect the brain microenvironment. Finally, surgery, including deep brain stimulation, is pursued when PwP fail to respond positively to other treatment options. There is currently no cure for PD. In conclusion, the best strategy for treating PD is to hope to slow disorder progression and strive to achieve stability with neuroprotection. The ultimate goal of any management program is to improve the quality-of-life for a person with Parkinson's disease.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Treatment options for non-motor symptoms in late-stage Parkinson"s disease
    Coelho, Miguel
    Ferreira, Joaquim
    Rosa, Mario
    Sampaio, Cristina
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (04) : 523 - 535
  • [2] Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease
    Perez-Lloret, Santiago
    Rascol, Olivier
    [J]. CNS DRUGS, 2016, 30 (08) : 703 - 717
  • [3] Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease
    Santiago Perez-Lloret
    Olivier Rascol
    [J]. CNS Drugs, 2016, 30 : 703 - 717
  • [4] Treatment of motor and non-motor symptoms of Parkinson's disease with botulinum toxin A
    Jabbari, B.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 535 - 535
  • [5] Non-motor symptoms of Parkinson's disease
    Deuschl, G
    [J]. AKTUELLE NEUROLOGIE, 2003, 30 : S242 - S245
  • [6] Non-motor symptoms of Parkinson's disease
    Hou, Jyh-Gong Gabriel
    Lai, Eugene C.
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2007, 1 (02) : 53 - 64
  • [7] Non-motor symptoms in Parkinson's disease
    Chaudhuri, K. R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 1 - 1
  • [8] The non-motor symptoms in Parkinson's disease
    Mihancea, P.
    Brisc, C. M.
    Havasi, N.
    Brisc, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 122 - 122
  • [9] Non-motor symptoms in Parkinson's disease
    Borgohain, R.
    Venigalla, N. K.
    Mridula, R.
    Jabeen, S. A.
    Kanikannan, M. A.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S523 - S523
  • [10] Non-motor symptoms in Parkinson's disease
    Elfekih, M.
    Bedoui, I.
    Douma, B.
    Mansour, M.
    Derbali, H.
    Riahi, A.
    Meselmani, M.
    Zaouali, J.
    Mrissa, R.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S170 - S170